Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
NCT05113537
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +14 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT06039371
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT06931340
- Conditions
- Castration-Sensitive Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- Kaiser Permanente Dublin Dublin, California, United States
- Kaiser Permanente-Fremont Fremont, California, United States
NCT07200830
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- Providence Alaska Medical Center Anchorage, Alaska, United States
- AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
NCT06236139
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT05168618
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT06616155
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Rush University Chicago, Illinois, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
NCT04704505
- Conditions
- Castration-Resistant, Metastatic Prostate Adenocarcinoma, Prostate Adenocarcinoma
- Locations
-
- Amber Michalik Baltimore, Maryland, United States
- Moinhos de Vento Hospital Porto Alegre, Brazil
NCT04734730
- Conditions
- Castration-Sensitive Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT06145633
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT05054296
- Conditions
- Biochemically Recurrent Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
NCT07650240
- Conditions
- Adenocarcinoma of the Prostate, Advanced Prostate Adenocarcinoma, Advanced Prostate Cancer, +19 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT02099864
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +14 more
- Locations
-
- UCSF Medical Center-Mount Zion San Francisco, California, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT04685811
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Weill Cornell Medicine New York, United States
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT04471974
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +13 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Evergreen Park, Illinois, United States
- University of Michigan Ann Arbor, Michigan, United States
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis
NCT03317392
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
- Yale University New Haven, Connecticut, United States
A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer
NCT04190446
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
NCT04455750
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
NCT03902951
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
NCT05479578
- Conditions
- Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States